Robb Knie - 17 Jul 2023 Form 4 Insider Report for Hoth Therapeutics, Inc. (HOTH)

Role
CEO and President, Director
Signature
/s/ Hayley Springer as Attorney-In-Fact for Robb Knie
Issuer symbol
HOTH
Transactions as of
17 Jul 2023
Net transactions value
$0
Form type
4
Filing time
18 Jul 2023, 16:15:11 UTC
Previous filing
20 Sep 2022
Next filing
08 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOTH Options Award $0 +40,000 $0.000000 40,000 17 Jul 2023 Common Stock 40,000 $2.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were issued pursuant to the Issuer's 2022 Equity Incentive Plan and vested in full upon grant.